(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate

We are (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate CAS:709031-45-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate
CAS.NO:709031-45-8
Synonyms:(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate
(1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide,methanesulfonic acid
2-Azabicyclo[3.1.0]hexane-3-carboxamide, (1S,3S,5S)-, methanesulfonate
 
Physical and Chemical Properties:
Molecular Formula C7H14N2O4S
Molecular Weight 222.262
 
Specification:
Appearance:Off-white to light brown powder
Assay:≥97.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Saxagliptin(CAS:361442-04-8).

(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide methanesulfonate


Related News: In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.terc-butil (S) -3- (4-aminofenil) piperidina-1-carboxilato CAS:1171197-20-8 With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand.N- (4-nitrofenil) -3-oxobutanamida CAS:4835-39-6 Beijing will strengthen its monitoring of overseas drug market and collect global prices for imported medicines, Friday’s guideline said.231278-84-5 Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives.We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.

Related Products
Product Name
2,2,3,3-Tetrafluoro-1-propanol Cas:76-37-9 View Details
1,6-Bis(Dimethylamino)Hexane View Details
benzenesulfonic acid sodium salt Cas:515-42-4 View Details
3-chloropropionic acid Cas:107-94-8 manufacturer Ruxolitinib Cas:941678-49-5 manufacturer (3aR,4S,7R,7aS)-Hexahydro-4,7-methanoisobenzofuran-1,3-dione manufacturer 1-Bromo-2-fluoro-4-nitrobenzene manufacturer 4-Fluoronitrobenzene Cas:350-46-9 manufacturer